Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01373190
Other study ID # AU Epilepsy Study
Secondary ID
Status Completed
Phase N/A
First received June 2, 2011
Last updated June 20, 2013
Start date May 2011
Est. completion date April 2012

Study information

Verified date June 2011
Source Atlantic University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The specific aim is to determine if there are patterns of temperature differences in the abdominal and back regions of individuals with partial/focal onset epilepsy as compared to a non-epileptic control group. The hypothesis is that individuals with partial/focal onset epilepsy will have colder recorded temperatures in the abdominal area than individuals in a matched control group.


Description:

The concept of "Abdominal Epilepsy" has been described in the neurology literature. The present study seeks to amplify understanding of this clinical entity by measuring abdominal area and low back skin temperature changes which may be affected through the function of the abdominal ganglia, specifically the Celiac, Superior Mesenteric and Inferior Mesenteric Ganglia.

This not an intervention study. It is study comparing abdominal area and low back skin temperature in individuals with the Partial/Focal Onset Epilepsy with a match control group of individuals with no epilepsy history. The implications of the outcome of the finding any significant temperature changes between the experimental and control groups is great enough to warrant the highest level of scientific scrutiny that this registration permits.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria Experimental Group:

1. Diagnosis of Partial/Focal Onset Epilepsy (ICD9-CM 345.4 and 345.5)

2. Ages 18-70

Exclusion Criteria Experimental Group:

1. Pregnancy

2. Recent trauma such as motor vehicle accident or injury to the musculoskeletal system

3. Currently on medication, other than for epilepsy which may affect autonomic nervous system function, e.g. Glaucoma medication

4. If diagnosed with a condition which could affect abdominal area neurophysiologic functions.

1. Irritable bowel syndrome

2. Crohn's disease

3. Ulcerative colitis

4. Migraine headache with abdominal manifestation

Inclusion criteria Control group:

1. No history or diagnosis of any seizure disorder

2. Ages 18-70

Exclusion Criteria Control group:

1. Pregnancy

2. Recent trauma such as motor vehicle accident or injury to the musculoskeletal system

3. Currently on medication, other than for epilepsy which may affect autonomic nervous system function, e.g. Glaucoma medication

4. If diagnosed with a condition which could affect abdominal area neurophysiologic functions.

1. Irritable bowel syndrome

2. Crohn's disease

3. Ulcerative colitis

4. Migraine headache with abdominal manifestation

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Locations

Country Name City State
United States Epilepsy Foundation of Florida Miami Florida

Sponsors (2)

Lead Sponsor Collaborator
Atlantic University A.T. Still University of Health Sciences

Country where clinical trial is conducted

United States, 

References & Publications (2)

Henkel A, Noachtar S, Pfänder M, Lüders HO. The localizing value of the abdominal aura and its evolution: a study in focal epilepsies. Neurology. 2002 Jan 22;58(2):271-6. — View Citation

Zinkin NT, Peppercorn MA. Abdominal epilepsy. Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):263-74. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Thermographic imagery of the abdominal area State of the art thermographic imagery of the imagery of the abdominal area from the xyphoid bone to just above the public symphysis. It is hypothesized that the average temperature for the experimental group will be lower than the control group. Since this is a measurement or diagnostic study using thermographic imagery, there is no health risk to the subjects. Each experimental subject and each control subject will be seen once for the administration of the thermography imagery No
Secondary low back thermography imagery Besides abdominal area will also do theographic imagery of low back of subjects because of the possibility of dermatomal skin area temperature changes possibly related the "Abdominal Epilepsy" dysfunction of the Celiac, Superior Mesenteric and Inferior Mesenteric Ganglia one time for thermographic imagery No
Secondary side thermography imagery To capture possible dermatomal skin temperature effects will do thermographic imagery of the side or lateral aspect of the subjects. one time for thermographic imagery No
See also
  Status Clinical Trial Phase
Withdrawn NCT00982787 - Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy Phase 2
Completed NCT00898560 - Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive Phase 1
Recruiting NCT01735032 - Multimodal Imaging in Pre-surgical Evaluation of Epilepsy N/A
Completed NCT01090934 - Localizing the Epileptogenic Zone With High Resolution Electroencephalography N/A
Terminated NCT00391534 - EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy Phase 3
Terminated NCT01496612 - Buspirone Therapy for Localized Epilepsy Phase 2
Completed NCT00900237 - Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine Phase 1
Recruiting NCT04903314 - Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures Phase 1
Completed NCT00894478 - Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging N/A
Recruiting NCT03478852 - Investigating Epilepsy: Screening and Evaluation
Recruiting NCT01273129 - Surgery as a Treatment for Medically Intractable Epilepsy
Completed NCT00001666 - Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy N/A
Completed NCT00001932 - Serotonin Receptors in Seizure Disorders N/A
Completed NCT00908349 - Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy Phase 3
Completed NCT02076698 - Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy Phase 3
Completed NCT00706160 - Language Mapping in Patients With Epilepsy
Completed NCT01397968 - Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures Phase 2
Completed NCT01866111 - A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Phase 2
Completed NCT00957047 - Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy Phase 3
Terminated NCT01281956 - PRX-00023 Therapy in Localization-Related Epilepsy Phase 2